3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
10
Head and Neck Neoplasms
8
Neoplasms
3
Nasopharyngeal Carcinoma
3
Melanoma
3
Recurrence
2
Oropharyngeal Neoplasms
2
Lung Neoplasms
2
Breast Neoplasms
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Tongue Neoplasms
1
Thyroid Neoplasms
1
Thymus Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
fludarabine
5
Cyclophosphamide
5
aldesleukin
4
fludarabine phosphate
2
entinostat
2
Nivolumab
2
Adoptive Transfer
2
pembrolizumab
1
oncogene protein E7, Human papillomavirus type 16
1
bintrafusp alfa protein, human
1
Vorinostat
1
Sentinel Lymph Node Biopsy
1
Ritonavir
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Molecular Diagnostic Techniques
1
Magnetic Resonance Spectroscopy
1
Isotretinoin
1
Interleukin-2
1
Interferon-alpha
1
Indinavir
1
Immunotherapy
1
Immunohistochemistry
1
Ganciclovir
1
Fluorodeoxyglucose F18
1
Fentanyl
1
FAPI-46
1
E6 protein, Human papillomavirus type 16
1
Drug Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Penile Neoplasms
×
Immunotherapy
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled